Related Experiment Video
Updated: Jun 20, 2026
10:57
NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Proline-rich polypeptide complex (PRP) regulates secretion of inflammatory mediators by its effect on NF-kappaB
Agnieszka Zabłocka1, Jakub Siednienko, Małgorzata Mitkiewicz
1Department of Immunochemistry, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12 R. Weigla, 53-114 Wrocław, Poland.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 18, 2009
Summary
Proline-rich polypeptide complex (PRP) may help Alzheimer's disease by reducing inflammation. PRP inhibits the nuclear factor-kappaB (NF-kappaB) pathway, a key driver of inflammation in Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Biochemistry
Background:
- Alzheimer's disease (AD) involves inflammation and oxidative stress.
- Proline-rich polypeptide complex (PRP) exhibits immunomodulatory and cognitive-enhancing properties.
- The precise mechanism of PRP's therapeutic effects in AD remains unclear.
Purpose of the Study:
- To investigate the anti-inflammatory mechanisms of PRP in the context of Alzheimer's disease.
- To elucidate PRP's effect on the nuclear factor-kappaB (NF-kappaB) signaling pathway.
- To determine if PRP modulates inflammatory responses induced by lipopolysaccharide (LPS).
Main Methods:
- Investigated PRP's effect on reactive oxygen species, nitric oxide, and cytokine production induced by LPS.
- Assessed the impact of PRP on NF-kappaB activation and translocation.
- Analyzed the levels of IkappaB in the presence of PRP and LPS stimulation.
Main Results:
- PRP inhibited LPS-induced overproduction of reactive oxygen species, nitric oxide, and proinflammatory cytokines.
- PRP demonstrated inhibitory effects on LPS-induced NF-kappaB activity.
- PRP increased NF-kappaB activity in untreated cells, potentially by enhancing proteasome-mediated IkappaB degradation.
Conclusions:
- PRP's anti-inflammatory effects in AD may be linked to its modulation of NF-kappaB signaling.
- PRP's influence on NF-kappaB translocation and IkappaB degradation contributes to its therapeutic potential.
- PRP warrants further investigation as a therapeutic agent for Alzheimer's disease.
Related Concept Videos
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:09Cytoskeletal Linker Proteins - Plakins
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.